Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 15/20 | 0.79 |
| ▸ | PYGM | P11217 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6430877 | 0.95 | PYGL (0.84) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL7190031 | 0.93 | PYGL (0.85) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL6431547 | 0.93 | PYGL (0.85) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL6431225 | 0.91 | PYGL (0.82) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL6430923 | 0.90 | PYGL (0.82) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL6431952 | 0.89 | PYGL (1.00) | PYGLPYGMMAPT | |
| SCHEMBL6432282 | 0.88 | PYGL (0.84) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL6432466 | 0.88 | PYGL (1.00) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL6430873 | 0.86 | PYGL (0.82) | PYGLPYGMMEN1KMT2AMAPT | |
| SCHEMBL6435836 | 0.86 | PYGL (0.85) | PYGLPYGMMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6590118-B1 | Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) | NOVO NORDISK A/S (DK) | 2003-07-08 | — | — | US | disclosed |